THC Farmaceuticals, Inc. (CBDG)
OTCMKTS · Delayed Price · Currency is USD
0.0171
0.00 (0.00%)
Jan 22, 2026, 4:00 PM EST
THC Farmaceuticals Market Cap
THC Farmaceuticals has a market cap or net worth of $310.05 thousand as of January 23, 2026. Its market cap has decreased by -78.63% in one year.
Market Cap
310.05K
Enterprise Value
n/a
Revenue
18.52K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since February 19, 2014, THC Farmaceuticals's market cap has decreased from 13.45M to 310.05K, a decrease of -97.70%. That is a compound annual growth rate of -27.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 310.05K | -55.00% |
| Dec 30, 2025 | 689.00K | 413.51% |
| Dec 31, 2024 | 134.17K | -66.36% |
| Dec 27, 2023 | 398.90K | -82.04% |
| Dec 30, 2022 | 2.22M | 100.82% |
| Dec 30, 2021 | 1.11M | -55.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio-Path Holdings | 619.22K |
| Regenerative Medical Technology Group | 507.62K |
| Helix BioMedix | 449.42K |
| Actavia Life Sciences | 385.91K |
| Innovation Pharmaceuticals | 370.14K |
| Oncology Pharma | 334.65K |
| Hemagen Diagnostics | 312.33K |
| Ampio Pharmaceuticals | 292.64K |